HIP1601

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIP1601, covering 2022-11-09 to 2022-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease [Phase 3]